# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-212075
Filing Date
2026-05-07
Accepted
2026-05-07 16:25:17
Documents
72
Period of Report
2026-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | whwk-20260331.htm iXBRL | 10-Q | 2639437
2 | EX-31.1 | whwk-ex31_1.htm | EX-31.1 | 17088
3 | EX-31.2 | whwk-ex31_2.htm | EX-31.2 | 17066
4 | EX-32.1 | whwk-ex32_1.htm | EX-32.1 | 9469
5 | EX-32.2 | whwk-ex32_2.htm | EX-32.2 | 9455
| Complete submission text file | 0001193125-26-212075.txt |  | 10250722

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | whwk-20260331.xsd | EX-101.SCH | 1274610
76 | EXTRACTED XBRL INSTANCE DOCUMENT | whwk-20260331_htm.xml | XML | 1859516

Mailing Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960
Business Address 2 HEADQUARTERS PLAZA EAST BUILDING, 11TH FLOOR MORRISTOWN NJ 07960 551-321-2234
Whitehawk Therapeutics, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38560 | Film No.: 26953941
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)